Prof. Jianxiong Li 李建雄
Chief Physician, Professor
Department of Medical Oncology, Chinese PLA General Hospital (301 Hospital), First Medical Center, Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: CyberKnife therapy, precision radiotherapy, stereotactic radiotherapy, and targeted therapy for breast cancer, lung cancer, head and neck tumors, and pancreatic cancer.
Dr. Li is Chief Physician and Professor at the PLA General Hospital, serving as Deputy Director of the Radiotherapy Sub-specialty. With 20 years of clinical experience, Dr. Li led the development of radiotherapy guidelines for 12 common malignancies across 130 hospitals. Dr. Li holds positions including Chief Scientist for the National Key R&D Program and has received awards such as the Chinese Medical Association Science and Technology Progress Award (First Class).
Professional roles
- Chair, Radiotherapy Branch, China Medical Device Industry Association
- Vice Chair, Radiotherapy Branch, Wu Jieping Foundation
- Standing Committee Member, Radiotherapy Branch, Chinese Medical Doctor Association
- Standing Committee Member, Radiotherapy Branch, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Li Jianxiong). Papers usually list the name as Jianxiong Li or Li J.
Selected publications
31 papers on PubMed matched by name and affiliation; 17 as first or senior author since 2016. Most recent first- or senior-author papers:
- Hlife, 2026 (senior author): Berberine alleviates radiation-induced lung injury by promoting microbiota-derived inosine via the gut-lung axis. PubMed 42903936
- Adv Healthc Mater, 2026 (senior author): Co-Delivery of Cisplatin and Curcumin via ROS-Responsive Nanoparticles to Activate the cGAS-STING Pathway for Osteosarcoma Metalloimmunotherapy. PubMed 41334674
- PeerJ, 2026 (senior author): PLK1 overexpression as a dual-role biomarker and therapeutic vulnerability in pulmonary adenocarcinoma. PubMed 41556056
- Mol Biomed, 2026 (senior author): Ionizing radiation: molecular mechanisms, biological effects, and therapeutic targets. PubMed 41507636
- Cancer Gene Ther, 2025 (senior author): Unveiling the role of the extracellular matrix in the osteosarcoma tumor microenvironment through integrated transcriptomics and experimental validation. PubMed 41057667
- Eur J Nutr, 2025 (senior author): Plant-based diets and the risk of lung cancer: a large prospective cohort study. PubMed 39891747
- Acta Biomater, 2025 (senior author): A metal coordination polymer nanoparticle synergistically re-establishes acidosis and enhances chemodynamic therapy for Glioblastoma. PubMed 39608659
- Adv Sci (Weinh), 2024 (senior author): Light-Activated In Situ Vaccine with Enhanced Cytotoxic T Lymphocyte Infiltration and Function for Potent Cancer Immunotherapy. PubMed 38953329
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion